CME Group (CME) Receiving Somewhat Favorable Press Coverage, Analysis Finds
News coverage about CME Group (NASDAQ:CME) has been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CME Group earned a daily sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 46.058465721668 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the news articles that may have impacted Accern Sentiment’s analysis:
- Coin flip will decide final price of Barrington-area waterfront house (dailyherald.com)
- CME Group Inc. (CME) Raised to “Buy” at BidaskClub (americanbankingnews.com)
- CME Group Inc. (NASDAQ:CME) COO Sells $1497358.05 in Stock – Gears Of Biz (gearsofbiz.com)
- Why Should You Retain CME Group (CME) in Your Portfolio – Nasdaq (nasdaq.com)
- CME Lowers Margins (agweb.com)
CME has been the subject of several research reports. Royal Bank Of Canada set a $130.00 price target on shares of CME Group and gave the company a “buy” rating in a research report on Monday, June 12th. UBS AG reissued a “buy” rating and issued a $134.00 price target (down previously from $136.00) on shares of CME Group in a research report on Monday, June 5th. Deutsche Bank AG reissued a “buy” rating and issued a $133.00 price target (down previously from $134.00) on shares of CME Group in a research report on Monday, May 15th. Jefferies Group LLC reissued a “buy” rating and issued a $128.00 price target on shares of CME Group in a research report on Monday, July 10th. Finally, Citigroup Inc. began coverage on CME Group in a research note on Wednesday, July 12th. They set a “buy” rating and a $140.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $131.63.
CME Group (NASDAQ CME) traded up 0.02% during midday trading on Friday, hitting $125.39. The stock had a trading volume of 1,048,291 shares. The firm has a market cap of $42.62 billion, a price-to-earnings ratio of 25.60 and a beta of 0.73. The firm has a 50 day moving average of $123.50 and a 200 day moving average of $121.16. CME Group has a 52 week low of $98.95 and a 52 week high of $127.96.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating the consensus estimate of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The company had revenue of $925 million for the quarter, compared to analysts’ expectations of $931.05 million. During the same period last year, the firm posted $1.14 earnings per share. CME Group’s revenue was up 2.1% compared to the same quarter last year. Equities research analysts predict that CME Group will post $4.80 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.11%. CME Group’s dividend payout ratio (DPR) is presently 53.99%.
In other CME Group news, President Bryan T. Durkin sold 9,200 shares of the stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $125.13, for a total value of $1,151,196.00. Following the transaction, the president now owns 70,938 shares of the company’s stock, valued at $8,876,471.94. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Kathleen M. Cronin sold 8,125 shares of the stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total value of $1,034,718.75. Following the completion of the transaction, the insider now directly owns 38,174 shares in the company, valued at approximately $4,861,458.90. The disclosure for this sale can be found here. In the last three months, insiders sold 91,085 shares of company stock worth $11,242,896. 0.61% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This report was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2017/08/19/somewhat-favorable-press-coverage-somewhat-unlikely-to-affect-cme-group-cme-share-price-updated-updated-updated.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.